ABD - İngilizce - NLM (National Library of Medicine)

astellas pharma us, inc. - micafungin sodium (unii: is1up79r56) (micafungin - unii:r10h71bswg) - mycamine® is indicated for:    •     treatment of candidemia, acute disseminated candidiasis, candida peritonitis and abscesses in adult and pediatric patients 4 months of age and older [see clinical studies (14.1) and use in specific populations (8.4)].    •    treatment of candidemia, acute disseminated candidiasis, candida peritonitis and abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age [see use in specific populations (8.4)] .    •    treatment of esophageal candidiasis in adult and pediatric patients 4 months of age and older [see clinical studies (14.2)] .    •    prophylaxis of candida infections in adult and pediatric patients 4 months of age and older undergoing hematopoietic stem cell transplantation [see clinical studies (14.3)] . limitations of use    •    the safety and effectiveness of mycamine have not been established for the treatment of candidemia with meningoencephalitis and/or ocular dissemin